showed a trendp = 0.078
33(19.6%) patients had HPR and increased platelet–fibrin clot strength and showed a trend for association with higher ischemic risk (HR 2.83 [CI 95% 0.70–8.06], p = 0.078).
33(19.6%) patients had HPR and increased platelet–fibrin clot strength and showed a trend for association with higher ischemic risk (HR 2.83 [CI 95% 0.70–8.06], p = 0.078).